Analystreport

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at Citigroup Inc. from $19.40 to $21.00.

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report